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Carotid endarterectomy (CEA) has become an
exceptionally safe procedure in contemporary clinical
practice, with a very low rate of neurologic complica-
tions.1 Most perioperative strokes are believed to
result from either intraoperative cerebral ischemia or
perioperative thromboembolism.2 Therefore, when a
patient awakens in the operating room after CEA with
a new neurologic deficit, immediate reexploration is
indicated. In the absence of a technical imperfection at
the endarterectomy site or acute thrombosis, treat-
ment is typically conservative, and the potential for
complete neurologic recovery is not good. We recent-
ly performed a CEA on a patient who awakened with
a profound neurologic deficit believed to be a result of
intraoperative thromboembolism. The patient was
successfully treated with an immediate postoperative
superselective urokinase infusion. To our knowledge
this is the first case in which urokinase was adminis-
tered in the immediate postoperative period in the
angiography suite to reverse a neurologic deficit
resulting from an intraoperative cerebral thromboem-
bolism complicating a CEA.
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A 42-year-old man with a high-grade left internal carotid artery (ICA) stenosis demon-
strated on a duplex scan was referred to us. A cerebral arteriogram confirmed a greater
than 90% left internal carotid stenosis, but with the unexpected finding of a moderate
amount of thrombus in the proximal ICA. He underwent emergent left carotid
endarterectomy, but during the operation, only a small amount of thrombus was iden-
tified as adherent to the atherosclerotic plaque. He awakened in the operating room with
a dense right hemiplegia and aphasia. Immediate reexploration demonstrated a patent
endarterectomy site, a distal thromboembolectomy was performed without extraction of
thrombus, and urokinase (250,000 units) was infused into the distal ICA. He reawak-
ened with an unchanged right hemiplegia and aphasia. The patient then underwent an
urgent postoperative carotid and cerebral arteriogram that demonstrated an embolus to
the middle cerebral artery. He was treated with the superselective infusion of urokinase
(500,000 units), with almost complete resolution of the clot. Over the course of the next
48 hours, the patient made a nearly complete neurologic recovery, and he was discharged
from the hospital with only a slight facial droop. At 2 months’ follow-up he was com-
pletely neurologically healthy. To our knowledge this is the first reported case of uroki-
nase administered in the immediate postoperative period in the angiography suite to
treat a thromboembolus complicating a carotid endarterectomy. (J Vasc Surg
2000;31:1033-7.)
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CASE REPORTS
CASE REPORT
A 42-year-old construction worker went to his commu-
nity hospital with the acute onset of dizziness and discol-
oration of the toes of both feet. His past medical history was
significant for hypertension, heavy smoking, and chronic
obstructive pulmonary disease; there was a strong family
history of coronary artery disease. There was no prior his-
tory of neurologic symptoms or peripheral vascular disease.
Pertinent findings on physical examination included palpa-
ble dorsalis pedis and posterior tibial pulses bilaterally, mild
cyanotic discoloration of all 10 toes, and a left carotid bruit.
He received heparin intravenously and underwent an exten-
sive workup, including lower extremity arterial and venous
Doppler scanning examinations, chest and abdominal com-
puterized tomographic (CT) scans, and an echocardiogram.
All the results were negative. However, a carotid duplex
scanning evaluation revealed a high-grade left internal
carotid artery (ICA) stenosis, and the patient was trans-
ferred to the Johns Hopkins Hospital 2 days after presenta-
tion for further evaluation and treatment. On presentation
to our institution his toes had markedly improved, he con-
tinued to have normally palpable pedal pulses, and he was
neurologically intact. The results from a transesophageal
echocardiogram were negative. A carotid arteriogram
demonstrated a greater than 90% left internal carotid steno-
sis and a moderate amount of luminal thrombus associated
with the stenosis (Fig 1).
The patient was taken immediately from the angiogra-
phy suite to the operating room and underwent CEA with
an indwelling shunt under general anesthesia. During the
operation, a high-grade stenosis was confirmed in a long
atherosclerotic plaque, but there was only a minimal
amount of thrombus associated with an ulcer. The patient
immediately awakened and exhibited a dense right hemi-
plegia and apparent aphasia. He underwent immediate
reoperation, and the vessel was found to be patent, with-
out technical deficit or thrombus. There was brisk back-
bleeding from the distal ICA. A balloon thromboem-
bolectomy procedure was performed, but no thrombus
was extracted. An intraoperative arteriogram was per-
formed that confirmed ICA flow into the brain, but with
inadequate visualization of the intracerebral vessels.
Urokinase (250,000 units) was infused into the distal
ICA, and the incision was closed over a closed-suction
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Fig 1. Preoperative carotid arteriogram demonstrating
severe left internal carotid stenosis and associated intralu-
minal thrombus. A, Lateral view. B, anteroposterior view.
Fig 2. Postoperative selective left carotid arteriogram. Note
occlusion of the left MCA (A). After gentle catheter manip-
ulation of the occluding thrombus, partial antegrade flow is
restored (B).
A B A
B
drain. The patient again awakened in the operating room
with a dense right hemiplegia and aphasia.
The patient had a head CT scan, which ruled out an
intracerebral hemorrhage. He then underwent a cerebral
arteriogram, which demonstrated an abrupt occlusion of
the left middle cerebral artery (MCA) (Fig 2, A). Through
a 6-French introducer sheath in the right femoral artery and
after the administration of heparin (5000 units), a 6-French
Envoy MPC–guiding catheter (Cordis Corp, Miami, Fla)
was advanced in the proximal left common carotid artery,
and a Turbotracker-18 microcatheter (Boston Scientific,
Natick, Mass) was advanced coaxially to the left MCA over
a Transcend-14 guide wire (Boston Scientific) under fluo-
roscopic control using road map guidance. The tip of the
guide wire was then carefully advanced through the clot,
and gentle mechanical disruption of the clot was per-
formed, allowing immediate reperfusion of distal MCA
branches (Fig 2, B). The tip of the catheter was then placed
within the clot, and then the superselective injection of
urokinase (500,000 units) was performed. The completion
arteriogram, which was performed approximately 6 hours
after the patient awakened from surgery with his deficit,
demonstrated reperfusion of the left MCA territory with
only minimal delayed filling of some temporal branches (Fig
3). After this, the patient was appropriately following com-
mands and exhibited good strength in the right leg, but had
persistent paralysis of the right arm. He received an intra-
venous drip of heparin (1000 U/h) and was taken to the
intensive care unit for monitoring.
Over the next 8 hours the patient began to move his
right arm, manifested normal strength in the right leg, and
was speaking with some dysarthria. During the next 72
hours the patient exhibited normal right-sided strength
and was speaking coherently. On his sixth postoperative
day the patient was ambulating independently, tolerating a
regular diet, and speaking normally. With symmetric upper
and lower extremity strength and sensation and with only
a slight facial asymmetry, he was discharged on warfarin.
Before discharge, a head CT scan confirmed a small infarct
involving the left lentiform nucleus. On the advice of our
hematology consultants and in view of the necessity for
ongoing anticoagulation that might confound the analysis,
a hypercoagulability workup was deferred. At 2 months’
follow-up the patient was neurologically healthy. No
anatomic etiology for the patient’s “blue toes” was identi-
fied, and his peripheral arterial perfusion remains normal.
DISCUSSION
Over the past two decades thrombolytic therapy
has assumed a role in the management of acute arte-
rial occlusive disease, primarily involving the lower
extremities. Although interest in the treatment of
patients with acute stroke with systemic thromboly-
sis dates back to the 1950s, the efficacy of this
approach has largely been limited by high rates of
cerebral hemorrhage.3 Over the last decade, howev-
er, there has been a renewal of interest in the man-
agement of patients with acute ischemic stroke using
the selective intra-arterial infusion of thrombolytic
agents, and the results have improved when com-
pared with systemic administration. It is clear from
this experience that the direct infusion of the throm-
bolytic agent into the occluding thrombus as soon as
possible after the onset of symptoms is the key to
limiting ischemic brain injury and minimizing the
risk of hemorrhagic complications.4 One may there-
fore reasonably infer that the patient who experi-
ences an acute thromboembolic complication of
CEA would be an ideal candidate for catheter-direct-
ed thrombolysis and that intraoperative administra-
tion would be the most expeditious strategy.5
Although intraoperative thrombolysis has
assumed an increasingly accepted role in the manage-
ment of patients undergoing surgery for acute limb
ischemia, experience with intraoperative intra-
cerebral thrombolysis is scant. Barr et al5 reported the
first successful case in 1995, in which 500,000 units
of urokinase was infused through a microcatheter that
was placed into an MCA clot under fluoroscopic con-
trol to treat an embolus detected during a CEA, with
complete clot resolution and full neurologic recovery.
Subsequently, Comerota and Eze6 reported the case
of a 65-year-old man who awakened with a right
hemiplegia resulting from acute thrombosis of the left
anterior cerebral artery during CEA. The man was
treated intraoperatively with an infusion of urokinase
(1 million units) that was delivered through the side-
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Fig 3. Completion of left carotid arteriogram after super-
selective administration of urokinase (500,000 units) into
the MCA thrombus. Note nearly complete recanalization.
port of the indwelling carotid shunt, with complete
clot lysis and significant neurologic improvement. In
another report, a patient with an acute cervical ICA
thrombosis and an MCA embolism underwent simul-
taneous CEA and intraoperative intracerebral throm-
bolysis with 500,000 units of urokinase.7 Eckstein et
al8 have recently reported a series of four men and
one woman, ranging in age from 55 to 72 years, who
underwent CEA and intraoperative thrombolysis with
500,000 units of urokinase for treatment of throm-
boembolic occlusions of the MCA (n = 4) and ante-
rior cerebral artery (n = 1). Two of these patients
received the thrombolytic infusion during an emer-
gency reexploration after new neurologic deficits
developed 2 and 3 hours after the initial CEA. There
was one postoperative death due to stroke, two
patients made complete neurologic recoveries, and
two patients were discharged with mild neurologic
deficits.8
In this case report, imaging limitations in the
operating room precluded our ability to adequately
visualize the intracerebral vasculature. Nevertheless,
according to the preoperative arteriogram (Fig 1)
and the relative paucity of thrombus found in the
patient’s ICA, a distal thromboembolus was the most
likely explanation for the patient’s profound neuro-
logic deficit. In view of the location of the embolus,
as depicted during the selective postoperative carotid
arteriogram (Fig 2), it is not surprising that the intra-
operative administration of 250,000 units of uroki-
nase into the distal cervical ICA did not achieve the
desired clinical outcome. In the absence of this imag-
ing capability, we believed it was more appropriate to
obtain a formal carotid arteriogram in the angiogra-
phy suite in the hopes of performing a superselective
infusion of urokinase postoperatively, rather than
persisting with an infusion of a much higher dose, as
others have reported.6
Previous work has indicated that the risk of cere-
bral hemorrhage increases if the thrombolytic infu-
sion is initiated more than 6 hours after the onset of
the ischemic insult,9 and we could treat our patient
within that window. Furthermore, we believed the
risk-benefit ratio clearly supported an aggressive
attempt at thrombolysis in view of the patient’s
young age, his profound neurologic deficit, and the
potential for neurologic recovery if complete
recanalization of the MCA could be achieved, as
demonstrated in previous angiographically con-
trolled trials.6 Although we recognized the potential
for bleeding into the surgical wound, we believed
the likelihood of that complication was small
because of the short half-life (14 minutes) of uroki-
nase and the relatively low dose delivered over a
short duration by selective catheter infusion.
Furthermore, a drain had been left in place after the
CEA, and the patient was closely monitored after
thrombolysis in the intensive care unit.
To our knowledge, this is the first report of a
patient undergoing immediate postoperative super-
selective urokinase infusion in the angiography suite
for a thromboembolic complication of CEA. On the
other hand, Katzan et al10 reported on 6 patients
who were treated with intra-arterial thrombolysis for
ischemic strokes developing from 2 to 14 days
(mean, 6 days) after major cardiac surgical proce-
dures. Four patients were treated with urokinase
(40,000-500,000 units), and two patients received
tissue plasminogen activator (25 and 50 mg).
Recanalization of the intracerebral thrombus was
complete in one case, partial in three cases, and
minor in two cases. Four patients improved clinical-
ly, and one died of cerebral edema. No patient expe-
rienced a significant systemic bleeding complication,
and only one patient had a small asymptomatic cere-
bellar hemorrhage.10 Mechanical manipulation of
the clot to allow recanalization of the affected vessel
with the lowest thrombolytic drug dose (Fig 2) was
carried out in each patient, as in our patient.10
In summary, although the patient undergoing
CEA, who may be a potential candidate for catheter-
directed thrombolysis administered intraoperatively or
immediately postoperatively, will most likely be
encountered infrequently in the practice of most busy
carotid surgeons, this strategy does offer an opportu-
nity for dramatic recovery of neurologic function and
should be part of our therapeutic armamentarium.
Our case and the experience of others indicate that this
treatment is most appropriate for the patient in whom
one suspects a thrombotic intracerebral arterial occlu-
sion. It is unlikely that atheroembolic debris, which is
the more common cause of intraoperative embolic
stroke, would likely respond to lysis. In other words,
the decision to attempt intracerebral thrombolysis in
the patient who experiences an apparent intraoperative
stroke is a clinical judgment that should be made on a
case-by-case basis. As in the management of a patient
who is seen with an ischemic stroke de novo, precise
angiographic localization of the offending thrombus
and selective lytic infusion at the earliest possible hour
will offer the greatest chance for successful lysis and
minimize the risk of hemorrhagic transformation. If
that imaging capability is available in the operating
room, intraoperative thrombolytic therapy will allow
the most expeditious treatment. On the other hand, in
the absence of this capability and if an interventional
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neuroradiology team is available, rapid transfer of the
patient to the angiography suite, as in the present case,
is a viable option with the potential for achieving a
gratifying neurologic recovery.
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